Organisation paid for research Program year 2025 Source: CMS Open Payments

Waypoint Research LLC

Neither a doctor nor a teaching hospital

Research payments

$756,930

3 payments

Through program year 2025, Waypoint Research LLC is reported as receiving $756,930 in research payments, across 3 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$530,617	2
2024	Research	$226,313	1

Breakdown

Who paid Research payments · program years 2024–2025

E.R. Squibb & Sons, L.L.C. $756,930 3 payments

Studies the money was for Research payments · program years 2024–2025

A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) $530,617 2 payments
Phase 2 PoC in Early AD Patients - A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer s Disease (TargetT $226,313 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.